End Cash: The amount of cash held by the company for the given period.
Roivant Sciences Ltd. (ROIV) had End Cash of $2.73B for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$7.57M |
|
$-206.47M |
|
$0.20M |
|
$7.37M |
|
$292.54M |
|
$-284.96M |
|
$81.91M |
|
$-292.84M |
|
$-305.74M |
|
$-341.47M |
|
$-341.47M |
|
$-252.38M |
|
$-352.73M |
|
$-267.01M |
|
$-265.59M |
|
725.40M |
|
725.40M |
|
$-0.29 |
|
$-0.28 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$5.44B |
|
-- |
|
-- |
|
-- |
|
$249.74M |
|
$5.19B |
|
$5.19B |
|
$5.19B |
|
695.94M |
|
| Cash Flow Statement Financials | |
$-839.45M |
|
$-1.77B |
|
$-1.22B |
|
$6.55B |
|
|
End Cash |
$2.73B |
$-3.82B |
|
$289.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
33.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
91.00% |
|
674.76% |
|
674.76% |
|
-- |
|
740.02% |
|
521.77% |
|
$-844.05M |
|
-- |
|
-- |
|
-- |
|
-0.01 |
|
-- |
|
-- |
|
-- |
|
-6.58% |
|
-6.58% |
|
-6.28% |
|
-6.58% |
|
$7.45 |
|
$-1.16 |
|
$-1.16 |
|